TAZ 抗体 (AA 73-292) (Fluoro647)
Our Local Distributor
北京 101111
Quick Overview for TAZ 抗体 (AA 73-292) (Fluoro647) (ABIN8045286)
抗原
See all TAZ 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 73-292
-
原理
- Anti-Tafazzin/TAZ Antibody Fluoro647 Conjugated
-
特异性
- No cross reactivity with other proteins.
-
交叉反应 (详细)
- No cross-reactivity with other proteins.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E.coli-derived human Tafazzin/TAZ recombinant protein (Position: M73-R292).
-
亚型
- IgG
-
-
-
-
应用备注
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
有效期
- 12 months
-
-
- TAZ (Tafazzin (TAZ))
-
别名
- TAZ
-
背景
-
Background: Tafazzin?is a?protein?that in humans is encoded by the?TAFAZZIN?gene. This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Gene Full Name: tafazzin, phospholipid-lysophospholipid transacylase
-
基因ID
- 6901
-
UniProt
- Q16635
抗原
-